Insider · CIK 0002113137
Gilead Raday
Files at RDHL (RedHill Biopharma Ltd.). First filing Apr 22, 2026, latest Oct 6, 2026.
Gilead Raday files SEC Form 4 as COO at RDHL (RedHill Biopharma Ltd.). Since Apr 22, 2026, Gilead Raday has reported 0 open-market buys worth $0 and 2 open-market sells worth $3,005, the latest filed on Oct 6, 2026.
A track record needs three past buys with six months of prices behind them; Gilead Raday has 0, so none is measured yet.
The newest scored trade: sold $1,431 of RDHL on Oct 1, 2026, filed Oct 6, 2026, scored 5 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $3,005.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RDHL: RedHill Biopharma Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | RDHLsell RedHill Biopharma Ltd. | $1,431 14,310,000 shares | -7% | - | |
| 5Weak | RDHLsell RedHill Biopharma Ltd. | $1,574 15,740,000 shares | -6% | +11% from low-70% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | RDHL RedHill Biopharma Ltd. | SOpen-market sale Ordinary Shares | -14,310,000 | $0.00 | $1,431 | 176,910,000 | 7 d ago |
| Oct 1, 2026 | RDHL RedHill Biopharma Ltd. | MOption exercise American Depository Sharesderivative | +27,560,000 | $0.00 | $0 | 131,690,000 | 7 d ago |
| Apr 6, 2026 | RDHL RedHill Biopharma Ltd. | SOpen-market sale Ordinary Shares | -15,740,000 | $0.00 | $1,574 | 261,060,000 | Apr 22, 2026 |
| Apr 6, 2026 | RDHL RedHill Biopharma Ltd. | MOption exercise American Depositary Sharesderivative | +30,780,000 | $0.00 | $0 | 76,150,000 | Apr 22, 2026 |
Questions about Gilead Raday
Answered from the filings on this page, as of the latest one.
Is Gilead Raday buying or selling?
In the last 12 months Gilead Raday reported 0 open-market buys worth $0 and 2 open-market sells worth $3,005 on SEC Form 4; the latest was sold $1,431 of RDHL on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Gilead Raday's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gilead Raday has 0.
Where does Gilead Raday file Form 4?
Gilead Raday has filed Form 4 at RDHL (RedHill Biopharma Ltd.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.